Roche - The Science of Lebrikizumab

Agency: Langland

Langland and Roche Logos.png

Capture was commissioned by healthcare creative agency Langland to create a short animation to explain the inner workings of a new clinical trial into asthma medication. Our brief was to visualize the tiny particles and receptors that contribute to asthma attacks in a modern, none conventional way to lift the content above the swaths of conventional microscopic animation already out there.

Using low poly design influences we crafted a simple and abstracted representation of the new experimental drug "Lebrikizumab", showing in simplified form how it could work to help to potentially alleviate symptoms in asthma suffers.